Ledger.Open graph →
SEC Form D · filed July 16, 2025

Halia Therapeutics, Inc

Offering
$20.0M
Sold
$337K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Lehi, UT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Jim B. Savas · Lehi, UTDirectorJeffrey Burton · Salt Lake City, UTExecTodd S. Pedersen · Lehi, UTDirectorJared Bearss · Salt Lake City, UTDirectorJohn S. Kauwe · Salt Lake City, UTDirectorDavid Bearss · Salt Lake City, UTExec · DirectorGary B. Sabin · Lehi, UTDirectorJeffrey Burton · Salt Lake City, UTExecJim B. Savas · Lehi, UTDirectorDavid Bearss · West Valley City, UTExec · DirectorGary B. Sabin · Lehi, UTDirectorTodd S. Pedersen · Lehi, UTDirectorJared Bearss · Salt Lake City, UTDirectorJohn S. Kauwe · Salt Lake City, UTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗